Compare STOK & OPRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STOK | OPRA |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | Norway |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2019 | 2018 |
| Metric | STOK | OPRA |
|---|---|---|
| Price | $26.13 | $17.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 6 |
| Target Price | ★ $46.46 | $26.29 |
| AVG Volume (30 Days) | ★ 638.1K | 288.6K |
| Earning Date | 11-03-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 4.54% |
| EPS Growth | ★ 92.73 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $184,420,000.00 | N/A |
| Revenue This Year | N/A | $20.36 |
| Revenue Next Year | $39.98 | $15.27 |
| P/E Ratio | ★ N/A | $13.62 |
| Revenue Growth | ★ 404.50 | N/A |
| 52 Week Low | $20.32 | $11.71 |
| 52 Week High | $40.22 | $20.78 |
| Indicator | STOK | OPRA |
|---|---|---|
| Relative Strength Index (RSI) | 38.05 | 38.89 |
| Support Level | $25.21 | $17.39 |
| Resistance Level | $33.92 | $19.43 |
| Average True Range (ATR) | 1.15 | 0.42 |
| MACD | -0.17 | -0.02 |
| Stochastic Oscillator | 36.31 | 32.26 |
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
Opera Ltd is a consumer internet software company providing a diversified portfolio of high-performance web browsers and adjacent digital services to engaged user base The company has transitioned from browser developer to multi-faceted platform offering a products and services that include PC and mobile browsers, its Opera Gaming portals and development tools, Opera News content platforms, Opera Ads platform, as well as a number of AI and web3 products and services, such as MiniPay and Opera AI, to a user base.